Financial reports
10-K
2023 FY
Annual report
13 Mar 24
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
19 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
10-K
2021 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12 Apr 24
8-K
Minimally Invasive Medical Technology for Tumor Removal INVESTOR PRESENTATION MARCH 2024 Traditional Method Baird Medical Method
18 Mar 24
8-K
Entry into a Material Definitive Agreement
12 Mar 24
8-K
Minimally Invasive Medical Technology for Tumor Removal INVESTOR PRESENTATION JANUARY 2024 Traditional Method Baird Medical Method
26 Jan 24
8-K
Minimally Invasive Medical Technology for Tumor Removal INVESTOR PRESENTATION DECEMBER 2023 Traditional Method Baird Medical Method
12 Dec 23
8-K
Entry into a Material Definitive Agreement
1 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
26 Oct 23
8-K
Entry into a Material Definitive Agreement
26 Jun 23
8-K
Entry into a Material Definitive Agreement
8 Jun 23
8-K
Departure of Directors or Certain Officers
20 Apr 23
Registration and prospectus
425
Business combination disclosure
18 Mar 24
425
Business combination disclosure
12 Mar 24
425
Business combination disclosure
21 Nov 23
425
Business combination disclosure
1 Aug 23
425
Business combination disclosure
1 Aug 23
425
Business combination disclosure
26 Jun 23
425
Business combination disclosure
26 Jun 23
425
Business combination disclosure
26 Jun 23
425
Business combination disclosure
26 Jun 23
425
Business combination disclosure
26 Jun 23
Proxies
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
22 Mar 24
PRE 14A
Preliminary proxy
11 Mar 24
DEFA14A
Additional proxy soliciting materials
17 Oct 23
DEF 14A
Definitive proxy
26 Sep 23
PRE 14A
Preliminary proxy
5 Sep 23
DEF 14A
Definitive proxy
24 Mar 23
PRE 14A
Preliminary proxy
8 Mar 23
Other
UPLOAD
Letter from SEC
17 Jul 23
CORRESP
Correspondence with SEC
28 Jun 23
UPLOAD
Letter from SEC
13 Jun 23
UPLOAD
Letter from SEC
17 Mar 23
CORRESP
Correspondence with SEC
15 Mar 23
UPLOAD
Letter from SEC
13 Mar 23
EFFECT
Notice of effectiveness
21 Oct 21
CERT
Certification of approval for exchange listing
20 Oct 21
CORRESP
Correspondence with SEC
18 Oct 21
CORRESP
Correspondence with SEC
18 Oct 21
Ownership
SC 13G/A
Radcliffe Capital Management, L.P.
14 Feb 24
SC 13G/A
Sculptor Capital LP
14 Feb 24
SC 13G/A
Saba Capital Management, L.P.
9 Feb 24
4
Change in insider ownership
27 Oct 23
4
Change in insider ownership
15 May 23
SC 13G
Exos Asset Management LLC
10 May 23
4
Change in insider ownership
8 May 23
4
Change in insider ownership
2 May 23
3
Initial statement of insider ownership
24 Apr 23
SC 13G
Radcliffe Capital Management, L.P.
24 Apr 23